Company / Operating Income
PALVELLA THERAPEUTICS, INC. Operating Income History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$14.1M
FY2024
5-year range
-$43.5M / -$11.9M
FY2020-FY2024
Trend
-18.8%
vs FY2023
Sector context
#61 of 204
Health Care
What the data says
At -$14M, PALVELLA THERAPEUTICS, INC.'s operating income ranks #61 of 204 in the Health Care sector. Operating Income has fluctuated over the past 10 years, ranging from -$43M in FY2022 to -$12M in FY2023.
Based on SEC 10-K filings.
-$14M in FY2024.
Improved from -$43M to -$14M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#61 of 204 in Health CareTop 30% of 204This company -$14.1M Sector average $107.8M
▼
-113.1% below sector average
Key checks
Key Insights
- In FY2024, operating income decreased 18.8% year-over-year.
- Ranks #61 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2023.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$14.1M | -18.8% |
| FY2023 | -$11.9M | +72.7% |
| FY2022 | -$43.5M | -28.2% |
| FY2021 | -$33.9M | -24.9% |
| FY2020 | -$27.2M | +0.0% |
| FY2019 | -$27.2M | -86.1% |
| FY2018 | -$14.6M | +35.9% |
| FY2017 | -$22.8M | +0.0% |
| FY2016 | -$22.8M | -66.4% |
| FY2015 | -$13.7M | -90.1% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026